Immunoperoxidase localization of papillomavirus antigens in cervical dysplasia and vulvar condylomas.
Kurman RJ, Shah KH, Lancaster WD, Jenson AB.
Am J Obstet Gynecol. 1981 Aug 15;140(8):931-5. doi: 10.1016/0002-9378(81)90087-9.
Human papillomavirus (HPV) in vulvar dysplasia and carcinoma in situ.
Junge J, Poulsen H, Horn T, Hørding U, Lundvall F.
APMIS. 1995 Jul-Aug;103(7-8):501-10. doi: 10.1111/j.1699-0463.1995.tb01398.x.
Histopathologic features of vulvar vestibulitis.
Chadha S, Gianotten WL, Drogendijk AC, Weijmar Schultz WC, Blindeman LA, van der Meijden WI.
Int J Gynecol Pathol. 1998 Jan;17(1):7-11. doi: 10.1097/00004347-199801000-00002.
Prognosis of vulvar dysplasia and carcinoma in situ with special reference to histology and types of human papillomavirus (HPV).
Junge J, Poulsen H, Horn T, Hørding U, Lundvall F.
APMIS. 1997 Dec;105(12):963-71.
Imiquimod Is Effective in Reducing Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-Analysis.
Hamar B, Teutsch B, Hoffmann E, Hegyi P, Harnos A, Nyirády P, Hunka Z, Ács N, Bánhidy F, Melczer Z.
Cancers (Basel). 2024 Apr 22;16(8):1610. doi: 10.3390/cancers16081610.
Definition of precursors in gynecologic cancer.
Scully RE.
Cancer. 1981 Jul 15;48(2 Suppl):531-7. doi: 10.1002/1097-0142(19810715)48:1+<531::aid-cncr2820481316>3.0.co;2-c.
Immunohistochemical demonstration of papillomavirus antigen in cervical dysplasia and vulvar condyloma.
Toki T, Oikawa N, Tase T, Satoh S, Wada Y, Yajima A.
Gynecol Obstet Invest. 1986;22(2):97-101. doi: 10.1159/000298898.
Misdiagnosis of high-grade vulvar intraepithelial neoplasia (VIN III) as mild cervical intraepithelial neoplasia (CIN I) on Papanicolaou tests.
August CZ, Ganji M, Froula E.
Arch Pathol Lab Med. 2003 Jan;127(1):68-70. doi: 10.5858/2003-127-68-MOHGVI.
Vulvar dystrophy: a clinical follow-up.
Mahmud N, Murakami T, Gyotoku Y, Nakazima H, Ishimaru T, Yamabe T.
Asia Oceania J Obstet Gynaecol. 1992 Sep;18(3):231-8.
A prospective multicentre controlled study of Gaoweikang (Chinese multiherb extract-based tincture) used in high-risk HPV infections.
Chen LM, Cong Q, Wu D, Chen Y, Qiu LH, Hong ZB, Yang YB, Xu L, Wang LF, Huang LX, Li WR, Tang JP, Cao YG, Sui L.
Eur Rev Med Pharmacol Sci. 2023 Oct;27(19):8985-8992. doi: 10.26355/eurrev_202310_33922.
